Kimberly-Clark acquires Kenvue
Kimberly-Clark agreed to acquire Kenvue. Reported deal value: $48.7B. Status: Pending. Sector: Consumer Health Goods. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-29. Figures and status may change as filings and press coverage update.
Partners Shareholders Approve Kimberly - Clark $ 40B Acquisition of Tylenol Maker Kenvue Kimberly - Clark Chairman and CEO Mike Hsu said the milestone 'advances our efforts to create a preeminent global health and wellness leader that will raise the standard of care for billions of people around the world and generate significant value for shareholders.' by Sandra Engelland
Deal timeline
This transaction is classified in Consumer Health Goods with a reported deal value of $48.7B. Figures and status may change as sources update.